Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 20, Issue 5

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 20, Issue 5 (2011)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 20, Issue 5 (2011)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Volume 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer

César Gómez-Raposo, Marta Mendiola, Jorge Barriuso, David Hardisson & Andrés Redondo

Pages: 591-594

Published online: 31 Mar 2011

AbstractforFrom targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer | Full Text | References | PDF (166.5 KB)

196 Views
2 CrossRef citations
0Altmetric

Reviews

Article

New targeted therapies for gastric cancer

Yoshinari Asaoka MD PhD, Tsuneo Ikenoue & Kazuhiko Koike

Pages: 595-604

Published online: 16 Mar 2011

AbstractforNew targeted therapies for gastric cancer | Full Text | References | PDF (208.8 KB)

631 Views
16 CrossRef citations
0Altmetric

Article

Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer

Elizabeth Buck PhD & Mark Mulvihill PhD

Pages: 605-621

Published online: 30 Mar 2011

AbstractforSmall molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer | Full Text | References | PDF (1.2 MB)

671 Views
43 CrossRef citations
0Altmetric

Article

The Syk kinase as a therapeutic target in leukemia and lymphoma

Dimitar G Efremov MD PhD & Luca Laurenti MD

Pages: 623-636

Published online: 26 Mar 2011

AbstractforThe Syk kinase as a therapeutic target in leukemia and lymphoma | Full Text | References | PDF (515.8 KB)

1004 Views
39 CrossRef citations
0Altmetric

Article

Liu Hong MD PhD, Shujun Li MD PhD, Yu Han MD, Jianjun Du MD PhD, Hongwei Zhang MD, Jipeng Li MD PhD, Qingchuan Zhao MD, Kaichun Wu MD PhD & Daiming Fan MD PhD

Pages: 637-644

Published online: 28 Mar 2011

AbstractforAngiogenesis-related molecular targets in esophageal cancer | Full Text | References | PDF (194.9 KB)

169 Views
11 CrossRef citations
0Altmetric

Article

HIF prolyl hydroxylase inhibitors for anemia

Eugene Muchnik & Joshua Kaplan

Pages: 645-656

Published online: 16 Mar 2011

AbstractforHIF prolyl hydroxylase inhibitors for anemia | Full Text | References | PDF (405.5 KB)

1441 Views
65 CrossRef citations
0Altmetric

Article

Lysophosphatidic acid-1-receptor targeting agents for fibrosis

Chloé Rancoule, Jean-Philippe Pradère, Julien Gonzalez, Julie Klein, Philippe Valet, Jean-Loup Bascands, Joost P Schanstra & Jean-Sébastien Saulnier-Blache

Pages: 657-667

Published online: 24 Mar 2011

AbstractforLysophosphatidic acid-1-receptor targeting agents for fibrosis | Full Text | References | PDF (214.3 KB)

1401 Views
66 CrossRef citations
0Altmetric

Article

Novel agents for diffuse large B-cell lymphoma

Rajni Sinha MD MRCP, Nutan DeJoubner MD & Christopher Flowers MD MS

Pages: 669-680

Published online: 28 Mar 2011

AbstractforNovel agents for diffuse large B-cell lymphoma | Full Text | References | PDF (227.2 KB)

352 Views
11 CrossRef citations
0Altmetric

Drug Evaluations

Article

Aromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers?

Helen L Steed & Quincy S-C Chu

Pages: 681-690

Published online: 18 Mar 2011

AbstractforAromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers? | Full Text | References | PDF (238.7 KB)

296 Views
4 CrossRef citations
0Altmetric

Article

Pomalidomide therapy for myeloma

Stephen Schey & Karthik Ramasamy

Pages: 691-700

Published online: 18 Mar 2011

AbstractforPomalidomide therapy for myeloma | Full Text | References | PDF (336.2 KB)

771 Views
27 CrossRef citations
0Altmetric

Article

Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia

Jan Tack MD PhD & Pieter Janssen

Pages: 701-712

Published online: 22 Mar 2011

AbstractforAcotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia | Full Text | References | PDF (523.8 KB)

399 Views
38 CrossRef citations
0Altmetric

Key Paper Evaluation

Article

Inhaled phosphodiesterase type 5 inhibitors for cystic fibrosis: a new therapy for systemic disease?

Evaluation of: Lubamba B, Lebacq J, Reychler G, et al. Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice. Eur Respir J 37(1):72-78.

Sabina Antonela Antoniu MD PhD

Pages: 713-715

Published online: 24 Mar 2011

AbstractforInhaled phosphodiesterase type 5 inhibitors for cystic fibrosis: a new therapy for systemic disease? | Full Text | References | PDF (155.5 KB)

90 Views
1 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Investigational drugs for the treatment of acromegaly: new agents to transform therapy

Rosa Pirchio et al.

Review Article | Published online: 30 Apr 2024

Safety, tolerability, and pharmacokinetics of the novel RdRp inhibitor SHEN26 against SARS-CoV-2: a randomized, placebo-controlled, double-blind Phase I study in healthy subjects

Cheng Sun et al.

Article | Published online: 30 Apr 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 30 Apr 2024

Open Access

Drugs in preclinical and early clinical development for the treatment of chagas disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 30 Apr 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.20, Iss.5, 2011)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?